Industry Growth Insights published a new data on “Point-of-Care Infectious Disease Diagnostics & Testing Market”. The research report is titled “Point-of-Care Infectious Disease Diagnostics & Testing Market research by Types (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC), By Applications (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), By Players/Companies Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point-of-Care Infectious Disease Diagnostics & Testing Market Research Report
By Type
HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC
By Application
Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others
By Companies
Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Report Segments:
The global Point-of-Care Infectious Disease Diagnostics & Testing market is segmented on the basis of:
Types
HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Thermo Fisher Scientific Inc
- Roche
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMérieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics
Highlights of The Point-of-Care Infectious Disease Diagnostics & Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- Other Infectious Disease POC
- By Application:
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point-of-Care Infectious Disease Diagnostics & Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point-of-Care Infectious Disease Diagnostics & Testing is a type of laboratory testing that is performed onsite at the patient's bedside. This type of testing can be used to diagnose and/or monitor infections in patients who are unable to attend a traditional medical office or clinic.
Some of the major players in the point-of-care infectious disease diagnostics & testing market are Abbott, Thermo Fisher Scientific Inc, Roche, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioM©rieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point-of-Care Infectious Disease Diagnostics & Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point-of-Care Infectious Disease Diagnostics & Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point-of-Care Infectious Disease Diagnostics & Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size & Forecast, 2018-2028
4.5.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Y-o-Y Growth
4.5.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Absolute $ Opportunity
Chapter 5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
5.2.1 HIV POC
5.2.2 Clostridium difficile POC
5.2.3 HBV POC
5.2.4 Pneumonia or Streptococcus associated infections
5.2.5 Respiratory syncytial virus (RSV) POC
5.2.6 HPV POC
5.2.7 Influenza/Flu POC
5.2.8 Other Infectious Disease POC
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home
6.2.4 Assisted Living Healthcare Facilities
6.2.5 Laboratories
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point-of-Care Infectious Disease Diagnostics & Testing Analysis and Forecast
9.1 Introduction
9.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
9.6.1 HIV POC
9.6.2 Clostridium difficile POC
9.6.3 HBV POC
9.6.4 Pneumonia or Streptococcus associated infections
9.6.5 Respiratory syncytial virus (RSV) POC
9.6.6 HPV POC
9.6.7 Influenza/Flu POC
9.6.8 Other Infectious Disease POC
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home
9.10.4 Assisted Living Healthcare Facilities
9.10.5 Laboratories
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point-of-Care Infectious Disease Diagnostics & Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
10.6.1 HIV POC
10.6.2 Clostridium difficile POC
10.6.3 HBV POC
10.6.4 Pneumonia or Streptococcus associated infections
10.6.5 Respiratory syncytial virus (RSV) POC
10.6.6 HPV POC
10.6.7 Influenza/Flu POC
10.6.8 Other Infectious Disease POC
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home
10.10.4 Assisted Living Healthcare Facilities
10.10.5 Laboratories
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
11.6.1 HIV POC
11.6.2 Clostridium difficile POC
11.6.3 HBV POC
11.6.4 Pneumonia or Streptococcus associated infections
11.6.5 Respiratory syncytial virus (RSV) POC
11.6.6 HPV POC
11.6.7 Influenza/Flu POC
11.6.8 Other Infectious Disease POC
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home
11.10.4 Assisted Living Healthcare Facilities
11.10.5 Laboratories
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
12.6.1 HIV POC
12.6.2 Clostridium difficile POC
12.6.3 HBV POC
12.6.4 Pneumonia or Streptococcus associated infections
12.6.5 Respiratory syncytial virus (RSV) POC
12.6.6 HPV POC
12.6.7 Influenza/Flu POC
12.6.8 Other Infectious Disease POC
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home
12.10.4 Assisted Living Healthcare Facilities
12.10.5 Laboratories
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point-of-Care Infectious Disease Diagnostics & Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Type
13.6.1 HIV POC
13.6.2 Clostridium difficile POC
13.6.3 HBV POC
13.6.4 Pneumonia or Streptococcus associated infections
13.6.5 Respiratory syncytial virus (RSV) POC
13.6.6 HPV POC
13.6.7 Influenza/Flu POC
13.6.8 Other Infectious Disease POC
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point-of-Care Infectious Disease Diagnostics & Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home
13.10.4 Assisted Living Healthcare Facilities
13.10.5 Laboratories
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point-of-Care Infectious Disease Diagnostics & Testing Market: Competitive Dashboard
14.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Thermo Fisher Scientific Inc
14.3.3 Roche
14.3.4 Siemens Healthineers
14.3.5 BD & Company
14.3.6 Chembio Diagnostics Inc.
14.3.7 Trinity Biotech
14.3.8 Cardinal Health
14.3.9 Quest Diagnostics Inc.
14.3.10 Bio-Rad Labs Inc.
14.3.11 bioMérieux SA
14.3.12 Sight Diagnostics Ltd.
14.3.13 Gene POC
14.3.14 Trivitron Healthcare
14.3.15 OJ-Bio Ltd.
14.3.16 Ortho-Clinical Diagnostics
